chartexchange

GALT
Galectin Therapeutics Inc.
stockNASDAQ

Market OpenNov 19, 2026 3:12:25 PM EST
2.88USD-3.356%(-0.10)102,572
2.8700Bid2.9000Ask0.0300Spread

GALT Financials

In Q3 FY 2026 (ended ), Galectin Therapeutics Inc. (GALT) reported net income of −$3.53M, operating cash flow of −$2.27M, and assets of $13.01M (filed ).

Loading financial flows…